Cargando…
Traditional and Emerging Biomarkers in Asymptomatic Left Ventricular Dysfunction—Promising Non-Coding RNAs and Exosomes as Biomarkers in Early Phases of Cardiac Damage
Heart failure (HF) is one of the major causes of morbidity and mortality worldwide and represents an escalating problem for healthcare systems. The identification of asymptomatic patients with underlying cardiac subclinical disease would create an opportunity for early intervention and prevention of...
Autores principales: | Janjusevic, Milijana, Fluca, Alessandra Lucia, Ferro, Federico, Gagno, Giulia, D’Alessandra, Yuri, Beltrami, Antonio Paolo, Sinagra, Gianfranco, Aleksova, Aneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125492/ https://www.ncbi.nlm.nih.gov/pubmed/34066533 http://dx.doi.org/10.3390/ijms22094937 |
Ejemplares similares
-
Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era
por: Aleksova, Aneta, et al.
Publicado: (2021) -
From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury
por: Gagno, Giulia, et al.
Publicado: (2020) -
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review
por: Aleksova, Aneta, et al.
Publicado: (2021) -
The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure
por: Aleksova, Aneta, et al.
Publicado: (2022) -
Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis
por: Janjusevic, Milijana, et al.
Publicado: (2022)